Therapeutic Apheresis: New Indications and Emerging Evidence in 2026
A clinical review of therapeutic apheresis beyond established autoimmune uses—covering neurological, metabolic, and post-infectious indications supported by 2025-2026 evidence.
Clinical Immunology
Moderate EvidenceAutoimmunity
Molecular mimicry, tolerance breakdown, and integrative approaches to autoimmune conditions.
01
02
Vagus Nerve Stimulation for Rheumatoid Arthritis: Clinical Evidence and Patient Selection
VNS in rheumatoid arthritis — RESET-RA trial results, patient selection criteria, integration with DMARDs, and how bioelectronic medicine is reshaping RA treatment.
03
Hashimoto's Thyroiditis: A Functional Medicine Approach to Root-Cause Treatment
Discover how functional medicine addresses Hashimoto's thyroiditis beyond TSH levels—root causes, advanced testing, and evidence-based protocols to reduce antibodies and symptoms.
04
Peptides for Autoimmune Disease: A Physician's Evidence-Based Guide
Discover how immunomodulatory peptides like Thymosin Alpha-1, BPC-157, and LL-37 can help regulate immune dysfunction in autoimmune conditions. Clinical protocols and evidence.
05
Low-Dose Naltrexone (LDN): Clinical Evidence for Chronic Illness and Autoimmunity
Low-dose naltrexone modulates immune function and reduces neuroinflammation. Evidence-based overview of LDN dosing, mechanisms, and clinical applications.
06
Apheresis for Autoimmune Disease: A Physician's Clinical Guide to Blood Purification Therapy
How extracorporeal apheresis reduces autoantibody burden, inflammatory cytokines, and immune complex load in treatment-resistant autoimmune conditions.
07
Autoimmune Disease: Mechanisms and Treatment
Why the immune system attacks itself, what triggers autoimmunity, and how integrative medicine approaches treatment. By Dr. Julian Douwes.
